Pipeline update
Hoersholm, Denmark -- August 23rd 2017 – Oncology Venture Sweden AB:s (OV:ST) announces a pipeline update: At the inception of the Company, we promised five products in three years. In just two years, we now have six products secured – ahead of plan – with a seventh on the horizon. We believe that our strong oncology pipeline positions us as a very strong global player in anti-cancer drug development. We have global rights to six products and global rights to their corresponding Drug Response Predictors (DRP™) - a cutting- edge advantage for development of precision medicine for